STAR Therapeutics

About STAR Therapeutics

STAR Therapeutics is a biotechnology company focused on discovering and developing best-in-class antibody therapies to transform the lives of patients with serious diseases. The company emphasizes a distinctive approach to antibody therapeutics and has a programmatic focus on addressing unmet needs in bleeding disorders, notably von Willebrand disease, through its VEGA program. Based in South San Francisco, California, STAR Therapeutics positions itself as a team of experienced innovators advancing a pipeline-in-a-product strategy and leadership in antibody drug development.